Position in PFE
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$26,690,753
-$3,742,070 QoQ
Shares Held
1,108,420
+2.3% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#239
of 2,820 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026XPONANCE LLC holds $673,665,379 across 15 Drug Manufacturers - General names. PFE ranks #7 (4.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
222,559 | $266,943,963 | |
| 2 | JNJ |
Johnson & Johnson
|
466,851 | $118,566,148 | |
| 3 | ABBV |
AbbVie Inc.
|
350,912 | $88,303,495 | |
| 4 | MRK |
Merck & Co., Inc.
|
473,483 | $60,842,565 | |
| 5 | AMGN |
Amgen Inc
|
133,818 | $48,458,174 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
238,168 | $30,090,145 | |
| 7 | PFE |
Pfizer Inc
This page
|
1,108,420 | $26,690,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
444,025 | $25,584,720 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $26,690,753 | 1,108,420 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $30,432,823 | 1,083,790 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $23,711,174 | 952,256 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $22,284,221 | 874,577 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $21,806,328 | 899,601 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $21,662,380 | 854,869 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $22,583,609 | 851,248 | Shares | Sole | 2025-02-11 | |
| 2024-09-30 | $23,641,201 | 816,904 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $24,863,923 | 888,632 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $26,052,643 | 938,834 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $25,652,580 | 891,024 | Shares | Sole | 2024-01-31 | |
| 2023-09-30 | $26,508,833 | 799,181 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $27,073,948 | 738,112 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $30,101,301 | 737,777 | Shares | Sole | 2023-04-18 | |
| 2022-12-31 | $35,880,912 | 700,252 | Shares | Sole | 2023-01-24 | |
| 2022-09-30 | $26,178,457 | 598,228 | Shares | Sole | 2022-10-24 | |
| 2022-06-30 | $27,074,013 | 516,384 | Shares | Sole | 2022-08-02 | |
| 2022-03-31 | $27,346,415 | 528,229 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $30,773,198 | 521,138 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $17,886,955 | 415,879 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $17,361,194 | 443,340 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $17,619,192 | 486,315 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $17,864,592 | 485,319 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $17,601,816 | 479,614 | Shares | Sole | 2020-10-26 | |
| 2020-06-30 | $17,490,724 | 534,884 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||